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Apparent diffusion coefficient (ADC)Background and objective: Diffusion-weighted imaging has an emerging role for assess-
ment of focal and diffuse liver diseases. The aim of this study was to evaluate the diagnostic
performance of DWI for characterization of focal liver lesions (FLLs).
Patients and methods: This prospective study included 40 consecutive patients with 64 focal
liver lesions, who underwent MRI of the liver. All patients had one or more hepatic focal
lesion of diameter more than 1 cm. DWI was reviewed (b values of 0, 50 and 600 s/mm2)
and the mean ADC was calculated.
Results: Quantitative assessment using ADC map was more accurate (87.5%) than qualita-
tive assessment using DWI (75%) in characterization of FLLs. Mean ADC values of malignant
lesions (0.94 + 0.32  103 mm2/s) were significantly lower than those of benign lesions
(2.64 + 0.46  103 mm2/s), (P < 0.001). Using an ADC value above 1.6  103 mm2/s
offered the best accuracy in differentiation of malignant from benign lesions (86%).
Conclusion: DWI is a useful tool for FLLs characterization. Because of its known pitfalls and
limitations, mainly the considerable overlap of ADCs values between solid benign and
malignant lesions, it should be interpreted in combination with clinical data and conven-
tional MRI sequences.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Focal liver lesions (FLLs) are common in the general
population. FLLs could be classified into 3 clinical cate-
gories: first, benign lesions for which no treatment is
needed (hepatic hemangioma, focal nodular hyperplasia
(FNH), benign liver cyst, and focal fat sparing); second,
benign lesions for which treatment is required (hepaticadenoma, adenomatosis, biliary cystadenoma, hepatic
abscess, echinococcal cyst, granulomatous inflammation
and inflammatory psuedotumor of the liver); and third,
malignant mass lesions for which treatment is always
required if feasible (hepatocellular carcinoma (HCC),
cholangiocarcinoma, liver metastases from other primary
sites, biliary cystadenocarcinoma, hepatic angiosarcoma
and lymphoma) [1].
Differentiation between malignant and benign FLLs and
establishing the correct diagnosis are of great importance
in treatment planning for patients with liver neoplasms
and in patients without neoplasms for avoiding unneces-
sary liver biopsies.
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diagnosis of FLLs as it can accurately differentiate benign
frommalignant lesions in most of the cases [2]. Ultrasound
(US), computed tomography (CT) and magnetic resonance
imaging (MRI) are the common modalities used. A meta-
analysis study comparing contrast-enhanced ultrasound,
CT, and MRI in evaluating incidental FLLs showed nearly
similar diagnostic performance with specificities ranging
from 82% to 89% without significant difference in the sum-
mary receiver operating characteristic curve (ROC) [3].
Because of the ionizing radiation of CT and relative non-
availability of ultrasound contrast, MRI is considered the
imaging modality of choice for FLL characterization. It
relies on the signal characteristics of T1-weighted, T2-
weighted, and dynamic gadolinium-enhanced T1-
weighted imaging [4–6].
Diffusion weighted imaging (DWI) is a relatively recent
imaging tool, which enables qualitative and quantitative
assessment of tissue diffusivity without use of contrast
agent.
The sensitivity of a DWI sequence is characterized by its
b-value, which reflects the influence of the gradients in
DWI. The higher the b-value, the more sensitive the
sequence is to diffusion effects. DWI is performed with at
least two b-values. Diffusion is quantitatively expressed
in the apparent diffusion coefficient (ADC) which is related
to the molecular mobility of water molecules and reflects
tissue properties such as the size of the extracellular space,
viscosity and cellularity. Low ADC values reflect restricted
diffusion, and thus in highly cellular tissues. High ADC val-
ues denote areas with relative free diffusion, and thus in
low cellular tissues [7,8].
With advances in hardware and coil systems, DWI has a
high contrast resolution allowing accurate FLLs detection
and characterization [9]. There are an increasing number
of studies concerned about quantitative measurements of
apparent diffusion coefficient (ADC) in liver lesions; how-
ever, many discrepancies were founded in the reported
ADC values [10]. Thus, the purpose of this study was to
evaluate the qualitative and quantitative diagnostic perfor-
mance of DWI for characterization of FLLs and to reach the
best ADC cutoff for distinction between malignant and
benign lesions.2. Patients and methods
This study included 40 non-consecutive patients, 26
males and 14 females, ranging in age from 20- to 85 years
old (mean, 58 years), who underwent MR imaging of the
liver in MRI unit in Diagnostic Radiology Department at
Sohag University Hospital from April 2012 to April 2013.
The inclusion criteria were Adult patients who had one
or more FLLs with a diameter more than 1 cm. Exclusion
criteria were as follows: patients under age of 18 years,
patients had no FLLs or had FLLs with a diameter less than
1 cm or had previously treated lesions. Patients who did
not undergo DWI nor had non-interpretable DWI
sequences due to artifacts were also excluded.
Written consent was taken from the patients in accord
with the ethics committee of our institution.2.1. MRI protocol
All MRIs had been obtained by using 1.5-T machine
(Philips- Acheiva), Netherlands. Sense flex coil was applied.
Pulse sequences included axial breath-hold fast spine echo
T2-weighted images (TR/ TE = 1852/70 ms, flip angle = 90,
field of view = 375 mm, slice thickness = 7 mm, with
0.7 mm intersection gap and matrix = 192  192), axial
short tau inversion recovery (STIR) (TR/ TE = 669/70 ms,
flip angle = 180, field of view = 375 mm, slice thick-
ness = 7 mm, with a 0.7 mm intersection gap and
matrix = 192  192), axial dynamic T1-weighted fat-
suppressed spoiled gradient-recalled-echo sequence, using
magnifest 0.2 ml/kg body weight (TR/TE = 4.2/1.8 ms, flip
angle = 15, field of view = 375 mm, slice thickness = 7 mm,
with 1 mm intersection gap and matrix = 175  256),
respiratory-triggered axial fat-suppressed single-shot
echo-planar DW imaging (TR/TE = 3000/100 ms, flip
angle = 140, field of view = 395 mm, slice thick-
ness = 7 mm, with 0.7 mm intersection gap and
matrix = 384  381), and DWI was obtained at different b
values (0, 50 for FLLs detection], and 600 s/mm2 [for FLLs
characterization] within the same acquisition. Pixel-based
ADC maps were reconstructed on the workstation. Three
b values (0, 50, and 600 s/mm2) were used for ADC calcula-
tion. The ADC value of each FLL was calculated within a
region of interest (ROI) placed in the center of the assessed
lesion, covering more than 50% of its surface. In cases of
necrotic FLLs, measurements were taken only in the solid
part, trying to avoid inclusion within the ROI of any necro-
tic part. Each lesion was individually analyzed in cases
with multiple FLLs. Mean ADC measurement was calcu-
lated for each hepatic pathology.2.2. Image analysis
The following data were recorded for each FLL: site,
size, morphology, signal intensity of all used sequences
(dynamic contrast material–enhanced T1WI, T2W FSE,
STIR, DWI and ADC map).
The lesion was considered benign if it was hyperintense
on DW images at b = 0 s/mm2 and strongly decreased in
signal intensity at b = 600 s/mm2 and subjectively higher
an ADC than that of the liver, apart from regeneration nod-
ules (9 cases), those had low signal in T2WIs and hence low
signal at b = 0, and b = 600, while the lesion was considered
malignant if it was mildly to moderately hyperintense on
DW images at b = 0 s/mm2 and remained hyperintense at
b = 600 s/mm2 compared with liver parenchyma, with
ADC signal lower than that of the liver parenchyma. If
the above criteria were not obtained (e.g. isointense ADC
or there was a partial signal intensity decrease), the lesion
was considered indeterminate [11–13].
Our standard of reference was based on the histopatho-
logical findings in 21 patients (9 HCCs, 5 metastatic lesions,
3 cholangiocarcinomas, 2 liver abscesses, one intra hepatic
hematoma, and one FNH). Diagnosis of the remaining 19
cases was based on clinical data, typical MR imaging find-
ings (T2-weighted, and dynamic contrast material–en-
hanced T1-weighted images), findings of other imaging
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up results.2.3. Statistical analysis
Descriptive analyses of demographic, clinical, radiolog-
ical, and pathological characteristics were done. The vari-
ables studied were described with mean ± standard
deviation to measure the degree of dispersion of data
around their mean. T-student test was applied to test the
presence of significant differences between two compara-
ble qualitative variables (benign versus malignant),
depending on the features assessed. The receiver operating
characteristic curve was constructed and its parameters
(sensitivity, specificity, positive predictive value, and nega-
tive predictive value) as well as the accuracy for each ADC
threshold were estimated to identify the best ADC value to
distinguish between benign and malignant FLLs.
SPSS statistical software was used with P value less than
0.05 was considered to indicate a significant difference.4. Results
A total of 40 consecutive adult patients had 64 HFLs
with an average diameter of 3.4 cm (range from 1.2 to
14 cm) met all of the inclusion criteria, 26 males (65%)
and 14 females (35%), ranging in age from 20 to 85 years
old (mean, 58 years). Twenty-four patients (60%) pre-
sented with 36 malignant liver lesions; 20 metastases, 13Fig. 1. HCC in liver cirrhosis in a 45 year-old female patient. (A) Axial T2-weight
associated ascites. (B) DWI (b = 600) image shows the hyperintensity of the
(0.98  103mm2/s).hepatocellular carcinomas (Fig. 1) and 3 Cholangiocarcino-
mas (Fig. 2) and sixteen patients (40%) presented with 28
benign liver lesions; 12 hemangiomas (Fig. 3), 9 regenerat-
ing nodules, 3 cysts (Fig. 4), 2 abscesses (Fig. 5), 1 focal
nodular hyperplasia (Fig. 6) and 1 hematoma. The average
number of FLLs/patient was 1.6. None of the patients
simultaneously had benign and malignant liver lesions.
12 patients had a history of chronic liver disease (5
chronic hepatitis and 7 liver cirrhosis) and 6 patients had
history of primary malignancy (2 cancer breast, 2 renal cell
carcinoma, one cancer bladder (Fig. 7) and one lymphoma
(Fig. 8). The remaining 22 patients, who had no history of
malignancy or chronic liver disease, underwent MR imag-
ing for further evaluation of FLLs diagnosed by CT and or
US.
Analysis of signal intensity on the b-600 showed statis-
tically significant difference between benign and malig-
nant FLLs (p value <0.001) with sensitivity and specificity
of hyperintensity for malignant FLLs were 91.7% and
53.5% respectively while decreased hyperintensity showed
sensitivity and specificity for benign FLLs of 83.3% and
71.1% respectively. The overall accuracy of qualitative
DW images for FLLs characterization was 75% (48 of 64)
Table 1.
Analysis of signal intensity on the ADC map showed
that hypointensity on ADC map is 100% specific for malig-
nant FLLs diagnosis. On the other hand specificity of hyper-
intensity on the ADC map for benign FLLs was 97.2%. The
overall accuracy of ADC map in FLLs characterization was
87.5% Table 2.ed image shows moderately hyperintense right lobe large lesion. Note the
lesion. (C) ADC map shows hypointense lesion with low ADC value
Fig. 2. Cholangiocarcinoma in a 55 year-old female patient. (A) Axial T1-weighted image displays an ill-defined hypointense lesion (asterisk) within the left
lobe. (B) Axial T2-weighted image, the lesion is slightly hyperintense (arrows). (C) DWI (b = 600) image shows peripheral rim of hyperintensity, giving rise
to a ‘‘target-sign”(arrows). (D) On the ADC map, the lesion is isointense (arrows) with low ADC value (0.93  103mm2/s).
Fig. 3. Liver hemangioma in a 38 year-old female patient. (A) Axial T2-weighted image discloses a lobulated hyperintense lesion in the right lobe. (B) Axial
single-shot echo-planar DW image (b = 600), the hemangioma persists with high signal intensity (tissue with greater cellularity/T2 shine-through). (C) The
ADC map shows the lesion is isointense with a high ADC value (3.8  103 mm2/s).
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Fig. 4. Hepatic small simple cyst in a 45 year-old female patient. (A) Axial T2-weighted image discloses a tinny hyperintense lesion in the left lobe (arrow).
(B) Axial single-shot echo-planar DW image (b = 600), the lesion shows T2 shine-through rather than restricted diffusion (some signal loss occurring)
(arrow). (C) On the ADC map, the lesion is markedly hyperintense with high ADC value (3.1  103 mm2/s) (asterisk). (D) Axial T1-weighted image, the
hypointense left hepatic lobe cyst (arrow) is more difficult to see.
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Table 3. Mean ADC values of malignant lesions
(0.94 ± 0.32  103 mm2/s) were significantly lower than
those of benign lesions (2.64 ± 0.46  103 mm2/s) with a
significant overlap (Fig. 9).
Using 1.05 as a cutoff ADC value led to a sensitivity for
malignancy of 63.9% and specificity of 96.4% with 78.1%
accuracy. Using a higher ADC value, such as 1.6, the sensi-
tivity and specificity for malignancy were 100% and 67.9%
respectively with 86% accuracy and 100% negative predic-
tive value Table 4.5. Discussion
Most of liver masses arising in noncirrhotic livers are
benign. The most common solid benign lesions are heman-
giomas, adenomas, and FNH [14,15], while metastases are
the most commonly encountered malignant lesions [3].
HCC and intrahepatic cholangiocarcinoma occur in the set-
ting of chronic liver disease [16].
In most cases, the differential diagnosis of FLLs is
straightforward, as the majority of FLLs have a characteris-
tic imaging aspect allowing a confident final diagnosis;
however, imaging diagnosis of atypical FLL is difficult,
and follow-up and/or biopsy are often required [2].MRI is the imaging test of choice for liver-mass charac-
terization, demonstrating similar if not superior perfor-
mance to CT. DWI plays an emerging role for the
assessment of focal and diffuse liver diseases. DWI can be
easily included in routine liver MRI protocols, as it takes
a short time as two breathhold acquisitions and non-
contrast technique; so, it can be done for patients with sev-
ere renal insufficiency, at risk for nephrogenic systemic
fibrosis [9]. DWI is a measure of the ability of water mole-
cule protons to diffuse freely within intra- and extracellu-
lar environments. Therefore, DWI of FLL denotes cellular
density of the lesion, while ADC values are quantifiable
measures reflecting both diffusion and perfusion within
imaged tissue [16].
In the present study, qualitative (signal intensity on DW
images and ADC map) and quantitative (ADC value) were
used to differentiate between benign and malignant FLLs.
In accordance with the previous literature [11–13], we
used b value of 0, 50 and 600 s/mm2 for visual discrimina-
tion between benign and malignant FLLs, on the basis of
lesion morphology, signal intensity and degree of signal
intensity decrease with increasing b values, and it showed
75% overall accuracy for FLLs characterization compared
with 89.1% reported by Parikh et al. in their study [17].
The lower percentage of our results could be a result of
Fig. 5. Liver abscess in a 72 year-old male patient. (A) Axial T1-weighted image shows a multiloculated hypointense cystic lesion in the left lobe. (B) Axial
T1-weighted image following intravenous contrast injection at the same level of (A) and shows intense marginal enhancement. (C) Axial T2-weighted image
discloses a hyperintense abscess cavity. (D) Axial single-shot echo-planar DW image (b = 600), the abscess persists with high signal intensity with ADC
value [1.7  103mm2/s] (E).
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in hemangioma that is responsible for its high signal inten-
sity on b value 600 and consequently it could be mistaken
for malignant lesion [18], and T2 shine-through phe-
nomenon that was encountered in 11 (39.3%) benign FLLs
on b value 600.
T2 shine-through phenomenon describes a lesion that
shows restricted diffusion on DWI because of the long T2-
relaxation time rather than the limited mobility of the
water protons. The presence of T2 shine-through is known
by correlation of high- b –value images with the ADC map.
Areas demonstrating mainly T2 shine-through rather than
restricted diffusion have high diffusivity on the ADC map
and high ADC values [19], as it was confirmed in our results
with increased overall accuracy for FLLs characterization on
ADC map up to 87.5%. Therefore, DW images should be
interpreted in combination with the ADC map and conven-
tional MRI sequences to avoid misinterpretation.
Several studies have been suggested that ADC values
can discriminate between benign and malignant focal liverlesions [20–25], but many discrepancies in the reported
ADC values were encountered. This is mainly because of
using different techniques, scanning parameters and dif-
ferent b-values [21], in addition to the different liver
lesions assessed.
In accordance with the more performed techniques in
previous studies, 0, 50 and 600 s/mm2 b values were used
in the present study to calculate the ADC values and
images were obtained using triggered breathing.
In general, malignant FLLs have ADC values lower than
those of benign lesions, with overlap of variable degrees
[19]. Lower ADC values for most malignant lesions are
thought to be due to cellular membranes impeding the
water molecules mobility. However, solid benign lesions
with high cellularity also have low ADC values. On the
other hand, cystic and necrotic malignant lesions exhibit
high ADC values as a result of larger diffusion distances
caused by lost membrane integrity [21].
In the current study, Mean ADC values of malignant
lesions (0.94 ± 0.32  103 mm2/s) were significantly
Fig. 6. FNH in a 59 year-old female patient; (A) Axial T1-weighted image displays a well-defined large hypointense lesion within the left lobe. (B) Axial T2-
weighted image discloses T2 iso/hyperintense lesion with central markedly hyperintense scar, consistent with focal nodular hyperplasia. (C) Axial single-
shot echo-planar DW image (b = 600), the FNH is moderately hyperintense with more hyperintense central scar (D) On the ADC map, the lesion is isointense
with a relatively low ADC value (1.4  103mm2/s).
Fig. 7. Hepatic metastasis from cancer bladder in a 70 year-old male patient. (A) Axial fat suppressed T2-weighted image displays moderately hyperintense
right lobe focal lesion (arrow) and another ill-defined less bright left lobe lesion (arrow head). (B) & (C) DWI (b = 600) images shows three markedly
hyperintense lesions. (D) On the ADC map at A and B levels, the right lobe lesion is hypointense (arrow) with low ADC value (1.3  103 mm2/s).
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Fig. 8. Lymphoma in a 28 year-old female patient (A) Axial T2-weighted image displays an ill-defined slight hyperintense left lobe focal lesion (arrow). Note
the associated multiple enlarged paraortic and porta hepatis lymph nodes (asterisk). (B) DWI (b = 600) image shows obviously the hyperintense hepatic
lesion (arrow) and the enlarged lymph nodes (asterisk). (C) On the ADC map, both hepatic lesion (arrow) and lymph nodes (asterisk) are hypointense with
low ADC value (1.1  103 mm2/s).
Table 1
Signal intensity and accuracy of DWI at b value-600 for differentiation between benign and malignant focal liver lesions.
Lesion type Signal intensity at b value-600 s/mm2 Total (%) P value Overall accuracy (%)
Hyperintense (%) Decreased hyperintensity (%)
Benign HFLs 13 (46.4) 15 (53.6) 28 (100) <0.001 86
Malignant HFLs 33 (91.7) 3 (8.3) 36 (100)
* P value is highly significance (<0.001).
Table 2
Signal intensity and accuracy of ADC map for differentiation between benign and malignant focal liver lesions.
Lesion type Signal intensity on ADC map Total (%) P value Overall accuracy (%)
Hyperintense (%) Isointense (%) Hypointense (%)
Benign HFLs 26 (93) 2 (7) 0 (0) 28 (100) <0.001 87.5
Malignant HFLs 1 (2.8) 5 (13.9) 30 (83.3) 36 (100)
* P value is highly significance (<0.001).
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0.46  103 mm2/s) with overlap in-between.
As the most challenging task in FLLs diagnosis is to dif-
ferentiate between malignant and benign solid liver
tumors, detection of the best ADC cutoff value and its accu-
racy to distinguish malignant and solid benign liver lesions
are valuable.
Different ADC cutoffs (1.4–1.6  103 mm2/s) have
been reported in previous studies, with a sensitivity rangedfrom 74% to 100% and specificity ranged from 77% to 100%
for diagnosing malignant lesions [11,17,20,26–28]. How-
ever, the specificity decreased by exclusion of cysts and
hemangiomas, suggesting that the ADC cutoff is not as
effective in differentiation of malignant lesions from FNHs,
adenomas, or abscesses.
Our results reported accuracy of ADC cutoff for the diag-
nosis of malignant focal lesions, ranged from 78.1% to 86%
depending on ADC threshold used. Using ADC cutoff of
Table 3
Distribution and mean ADC values for benign and malignant focal liver lesions.
Lesion type Number of patients (%) Number of lesions (%) ADC value
Benign HFLs 16 (40) 28 (43.75) (0.67–5) 2.64 ± 0.46
Hemangioma 5 (12.5) 12 (18.75) (1.23–3.91) 3.36 ± 0.26
Regenerating Nodule 5 (12.5) 9 (14) (0.67–1.47) 0.88 ± 0.37
Abscess 2 (5) 3 (4.7) (1.6–4.21) 3.45 ± 0.64
Cyst 2 (5) 2 (3.1) (3–4.7) 3.85 ± 0.57
FNH 1 (2.5) 1 (1.6) 1.4 ± 0.4
Hematoma 1 (2.5) 1 (1.6) 5 ± 0.12
Malignant HFLs 24 (60) 36 (56.25) (0.54–1.6) 0.94 ± 0.32
HCC 12 (30) 13 (20.3) (0.78–1.6) 0.93 ± 0.37
Metastases 9 (22.5) 20 (31.25) (0.34–1.23) 0.89 ± 0.25
Cholangiocarcinoma 3 (7.5) 3 (4.7) (0.96–1.2) 1.13 ± 0.21
Note: HCC; Hepatocellular carcinoma, FNH; Focal nodular hyperplasia, ADC values are expressed as the lowest, highest and (mean) ADC values ± Standard
deviation.
Fig. 9. Box plot illustrating mean ADC values for benign and malignant HFLs.
Table 4
Diagnostic value of different ADC thresholds for Diagnosing Malignant FLLs.
ADC threshold Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
1.6 100 68 80 100 86
1.2 83.3 85.7 88.2 80 84.4
1.05 63.9 96.4 95.8 67.5 78.1
* P value is highly significance (<0.001).
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entiation of malignant and benign liver lesions (86%) with
a sensitivity of 100% and a specificity of 68% for malignant
lesions. Its strength was in its 100% negative predictive
value where ADC values above 1.6  103 mm2/s exclude
the malignant lesions. However, the relatively lower speci-
ficity compared with those of the literature could be
explained by inclusion of regenerating nodules (9 out of
28 benign lesions) in our series with a mean ADC value
of 0.88 ± 0.37  103 mm2/s which is parallel to that of
malignant lesions.By comparing our ADC cutoff with the literature, differ-
ences in sensitivity and specificity and accuracy are small.
The only study with significantly different results from
ours included 38 patients presented with 37 FLLs and
68% of the benign lesions were biliary cysts with signifi-
cantly higher ADC value than other lesions [20].
Some potential limitations are encountered in this
study; first is the limited image quality of single shot SE
echo-planar DW MR imaging, including low spatial resolu-
tion, poor SNR, and echo-planar imaging–related artifacts.
Second, the small number of patients relative to the high
1220 N.M.A. Hasan et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1211–1220variability in pathology included, lack of cases of adenomas
and only one case of FNH was included. Third, the unavail-
able histopathological findings in some cases (19 [47.5%]
cases).
6. Conclusion
DWI is a useful tool for FLLs characterization. Qualita-
tive DWI assessment is not sufficient alone and should be
combined with quantitative ADC value calculation. DWI
should be included in routine liver MR protocols, however,
because of its known pitfalls and limitations, mainly the
substantial overlap in the range of ADCs between solid
benign and malignant lesions, it should be interpreted in
combination with clinical history and conventional
sequences including contrast enhanced MRI.
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